Levels of Serum Ceruloplasmin Associate With Pediatric Nonalcoholic Fatty Liver Disease

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Pediatric Gastroenterology and Nutrition - JPGN

• Publication date

  2013-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/MPG.0b013e31827aced4PMID 23154483
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatic lipid metabolism and non-alcoholic fatty liver disease

  2017cited by this paper
• Epidemiology of Nonalcoholic Fatty Liver Disease

  2014cited by this paper
• Pediatric Nonalcoholic Fatty Liver Disease

  2013cited by this paper
• Pediatric nonalcoholic fatty liver disease.

  2013cited by this paper
• Regression Models for Categorical Dependent Variables Using Stata

  2013cited by this paper
• Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: Pathogenetic role of genetic background and intrauterine environment

  2012cited by this paper
• Early interplay of intra-hepatic iron and insulin resistance in children with non-alcoholic fatty liver disease.

  2011cited by this paper
• A Role for Low Hepatic Copper Concentrations in Nonalcoholic Fatty Liver Disease

  2010cited by this paper
• Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease.

  2010cited by this paper
• Ceruloplasmin/Transferrin Ratio Changes in Alzheimer's Disease

  2010cited by this paper
• Epidemiology of Non-Alcoholic Fatty Liver Disease

  2010cited by this paper
• Pathology of nonalcoholic fatty liver disease

  2010cited by this paper
• Severity of Liver Injury and Atherogenic Lipid Profile in Children With Nonalcoholic Fatty Liver Disease

  2010cited by this paper
• Ceruloplasmin/Transferrin System Is Related to Clinical Status in Acute Stroke

  2009cited by this paper
• Hepatic lipid metabolism and non-alcoholic fatty liver disease.

  2009cited by this paper
• Pediatric nonalcoholic fatty liver disease in 2009.

  2009cited by this paper
• Association between type two diabetes and non-alcoholic fatty liver disease in youth.

  2009cited by this paper
• Redox mechanisms in hepatic chronic wound healing and fibrogenesis

  2008cited by this paper
• Copper availability contributes to iron perturbations in human nonalcoholic fatty liver disease.

  2008cited by this paper
• Comparison of two automated spectrophotometric methods for ceruloplasmin measurement in pigs.

  2007cited by this paper
• Pathology of nonalcoholic fatty liver disease.

  2007cited by this paper
• A kinetic method amenable to automation for ceruloplasmin estimation with inexpensive and stable reagents.

  2007cited by this paper
• Design and validation of a histological scoring system for nonalcoholic fatty liver disease

  2005cited by this paper
• Immunohistochemical analysis of Mallory bodies in Wilsonian and non‐Wilsonian hepatic copper toxicosis

  2004cited by this paper
• Serum Transferrin Receptor : A Quantitative Measure of Tissue Iron Deficiency

  2003cited by this paper
• Ceruloplasmin metabolism and function.

  2002cited by this paper
• Transferrin gene polymorphism in Alzheimer's disease and dementia with Lewy bodies in humans.

  2002cited by this paper
• CDC growth charts; United States

  2000cited by this paper
• CDC growth charts: United States.

  2000cited by this paper
• Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

  1999cited by this paper
• Glutathione peroxidase‐like activity of caeruloplasmin as an important lung antioxidant

  1999cited by this paper
• Ceruloplasmin Enhances Smooth Muscle Cell- and Endothelial Cell-mediated Low Density Lipoprotein Oxidation by a Superoxide-dependent Mechanism*

  1996cited by this paper
• High ceruloplasmin levels in rats without high lipoprotein oxidation rates.

  1996cited by this paper
• Structure, oxidant activity, and cardiovascular mechanisms of human ceruloplasmin.

  1995cited by this paper
• Intact human ceruloplasmin oxidatively modifies low density lipoprotein.

  1994cited by this paper
• Automated latex agglutination immunoassay of serum ferritin with a centrifugal analyzer.

  1994cited by this paper
• Copper deficiency increases the susceptibility of lipoproteins and tissues to peroxidation in rats.

  1993cited by this paper
• The antioxidants of human extracellular fluids.

  1990cited by this paper
• Serum transferrin receptor: a quantitative measure of tissue iron deficiency.

  1990cited by this paper
• Role of free radicals and catalytic metal ions in human disease: an overview.

  1990cited by this paper
• Sensitive, direct colorimetric assay for copper in serum.

  1989cited by this paper
• Transcriptional regulation of ceruloplasmin gene expression during inflammation.

  1988cited by this paper
• Quantitative measurement of the total, peroxyl radical‐trapping antioxidant capability of human blood plasma by controlled peroxidation

  1985cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985influential reference
• [The antioxidant system of transferrin-ceruloplasmin in experimental hypercholesterolemia].

  1984cited by this paper
• The transferrin-ceruloplasmin antioxidant system in experimental hypercholesterolemia

  1984cited by this paper
• Oxygen toxicity, oxygen radicals, transition metals and disease.

  1984cited by this paper
• Ceruloplasmin: methods and clinical use.

  1982cited by this paper
• Inhibition of lipid peroxidation by the iron-binding protein lactoferrin.

  1981cited by this paper
• Novel chromogen for serum iron determinations.

  1981cited by this paper
• Automated assay of ceruloplasmin by kinetic analysis of o-dianisidine oxidation.

  1976cited by this paper
• Measurement of ceruloplasmin from its oxidase activity in serum by use of o-dianisidine dihydrochloride.

  1974cited by this paper
• Standardization of serum ceruloplasmin concentrations in international enzyme units with o-dianisidine dihydrochloride as substrate.

  1974cited by this paper
• Identification and purification of a non-ceruloplasmin ferroxidase of human serum.

  1970cited by this paper

• Diagnosis of liver diseases using ceruloplasmin – a preliminary study

  2026cites this paper
• The Vicious Circle of Metabolic Dysfunction-Associated Steatotic Liver Disease When Micronutrient Deficiency Drives Microbial Imbalance and Liver Injury

  2025cites this paper
• Uncovering hepatic transcriptomic and circulating proteomic signatures in MASH: A meta-analysis and machine learning-based biomarker discovery

  2025cites this paper
• Comparative analysis of gut microbiota in metabolic syndrome and obese children from Southeastern China

  2024cites this paper
• Obeticholic acid's effect on HDL function in MASH varies by diabetic status.

  2024cites this paper
• Elucidating cuproptosis in metabolic dysfunction-associated steatotic liver disease.

  2024cites this paper
• Copper and liver fibrosis in MASLD: the two-edged sword of copper deficiency and toxicity

  2024cites this paper
• Copper status and its relation to abdominal obesity indices and liver function in non-alcoholic fatty liver disease: a case-control study

  2024cites this paper
• STUDYING THE RELATIONSHIP OF COPPER AND ZINC CONCENTRATIONS IN BLOOD SERUM WITH INFLAMMATION MARKERS

  2023cites this paper
• Lipid dysmetabolism in ceruloplasmin‐deficient mice revealed both in vivo and ex vivo by MRI, MRS and NMR analyses

  2023cites this paper
• Involvement of essential trace elements in the pathogenesis of hepatitis C virus‑related chronic liver disease and nonalcoholic steatohepatitis

  2023cites this paper
• Relationship between dietary intake components and hepatic fibrosis in those with obesity before and 1 year after bariatric surgery.

  2023cites this paper
• Recent advances in the application of ionomics in metabolic diseases

  2023cites this paper
• Ceruloplasmin-Deficient Mice Show Dysregulation of Lipid Metabolism in Liver and Adipose Tissue Reduced by a Protein Replacement

  2023cites this paper
• Relationship Between Globulins in the Late Dry Period with Biochemical Parameters, Fertility and Culling of Cows within 90 Days after Calving

  2022cites this paper
• Copper-catalyzed dicarbonyl stress in NAFLD mice: protective effects of Oleuropein treatment on liver damage

  2022cites this paper
• Overweight and Obesity Are Positively Associated with Serum Copper Levels in Mexican Schoolchildren

  2022cites this paper
• A Novel Non-Invasive Approach Based on Serum Ceruloplasmin for Identifying Non-Alcoholic Steatohepatitis Patients in the Non-Diabetic Population

  2022cites this paper
• A Multidisciplinary Approach to the Diagnosis and Management of Wilson Disease: 2022 Practice Guidance on Wilson Disease from the American Association for the Study of Liver Diseases.

  2022cites this paper
• Mineral metabolism and ferroptosis in non-alcoholic fatty liver diseases.

  2022cites this paper
• Non-alcoholic fatty liver disease and liver secretome

  2022cites this paper
• NAFLD and the Gut-Liver Axis: Exploring an Undernutrition Perspective.

  2022cites this paper
• Copper exposure association with prevalence of non-alcoholic fatty liver disease and insulin resistance among US adults (NHANES 2011-2014).

  2021cites this paper
• The effect of nutritional education program on micronutrient intake in children with chronic liver disease: A clinical trial

  2021cites this paper
• Serum copper, ceruloplasmin, and their relations to metabolic factors in nonalcoholic fatty liver disease: a cross-sectional study

  2021cites this paper
• HEPATIC STEATOSIS IN THE MOUSE MODEL OF WILSON DISEASE COINCIDES WITH A MUTED INFLAMMATORY RESPONSE.

  2021cites this paper
• Association between blood copper and nonalcoholic fatty liver disease according to sex.

  2020cites this paper
• Novel predictive models using serum ceruloplasmin levels for hepatic steatosis in patients with chronic hepatitis B infection.

  2020cites this paper
• Metabolic dysregulation in the Atp7b−/− Wilson’s disease mouse model

  2020cites this paper
• Lipid and energy metabolism in Wilson disease

  2020cites this paper
• Biomarkers in Pediatric NAFLD

  2020cites this paper
• New mutation of the ceruloplasmin gene in the case of a neurologically asymptomatic patient with microcytic anaemia, obesity and supposed Wilson’s disease

  2020cites this paper
• Current Trends of Essential Trace Elements in Patients with Chronic Liver Diseases

  2020cites this paper
• DISTINCT PHENOTYPE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH LOW LEVELS OF FREE COPPER AND OF CERULOPLASMIN.

  2020cites this paper
• Non- Invasive Biomarkers and Their Diagnostic Utility in Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH)

  2019cites this paper
• Oxidative Stress Related to Iron Metabolism in Relapsing Remitting Multiple Sclerosis Patients With Low Disability

  2019cites this paper
• Obesity is associated with copper elevation in serum and tissues.

  2019cites this paper
• Copper Transport and Disease: What Can We Learn from Organoids?

  2019cites this paper
• Copper-Fructose Interactions: A Novel Mechanism in the Pathogenesis of NAFLD

  2018cites this paper
• Evaluation of the serum ceruloplasmin level before and after non-surgical periodontal therapy in patients with chronic periodontitis

  2018cites this paper
• A High-Calorie Diet Aggravates Mitochondrial Dysfunction and Triggers Severe Liver Damage in Wilson Disease Rats

  2018cites this paper
• Micronutrients in Nonalcoholic Fatty Liver Disease Pathogenesis

  2018cites this paper
• Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis

  2017cites this paper
• Non-Alcoholic Fatty Liver Disease and Nutritional Implications: Special Focus on Copper

  2017cites this paper
• Clinical implications of understanding the association between oxidative stress and pediatric NAFLD

  2017cites this paper
• Associations of Insulin Resistance and Glycemia With Liver Enzymes in Hispanic/Latino Youths: Results From the Hispanic Community Children’s Health Study/Study of Latino Youth (SOL Youth)

  2017cites this paper
• An exploratory study of BDNF and oxidative stress marker alterations in subacute and chronic stroke patients affected by neuropathic pain

  2017cites this paper
• Assessment of Concurrent Cellular Oxidative Stress with the Body Weight Gain in Serum of Obese Patients Undergoing to Surgical / Non-Surgical Strategies for Reducing an Excess Weight

  2016cites this paper
• Recognition and Management of Children with Nonalcoholic Fatty Liver Disease

  2016cites this paper
• Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase

  2016cites this paper
• The Potential Role of Iron and Copper in Pediatric Obesity and Nonalcoholic Fatty Liver Disease

  2015cites this paper
• Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease.

  2015cites this paper
• Biomarkers in nonalcoholic fatty liver disease.

  2014cites this paper
• Novel Bioimaging Techniques of Metals by Laser Ablation Inductively Coupled Plasma Mass Spectrometry for Diagnosis Of Fibrotic and Cirrhotic Liver Disorders

  2013cites this paper